Genotype Distribution and Noninvasive Fibrosis Assessment in Chronic HCV - Insights from a Tertiary Center in Eastern India
Bhowmick, J.; Das, R.; Barik, D.; Bagchi, A.; M, M.; Banerjee, S.
Show abstract
IntroductionHepatitis C virus (HCV) genotype distribution and fibrosis burden vary geographically and influence clinical management. Genotype 3 predominates in India and neighboring regions and is associated with steatosis and faster fibrosis progression. This study aims to characterize HCV genotypes, liver stiffness (FibroScan), and the comparative performance of non-invasive fibrosis markers (APRI, FIB-4) in patients from AIIMS Kalyani, West Bengal. MethodsBetween March 2023 and March 2025, a total of 1,105,120 patients attended the outpatient department and 33,287 were admitted to inpatient care at AIIMS Kalyani. Among them, 29,169 individuals were screened for anti-HCV antibodies. HCV seropositivity was detected in 140 patients (0.48%). Among these, 120 underwent HCV RNA PCR testing, of which 32 were confirmed RNA-positive and were enrolled for further evaluation in the Viral Hepatitis Treatment Clinic. Twenty seropositive patients were lost to follow-up. Detailed clinical, laboratory, and liver fibrosis assessments (FibroScan, APRI, FIB-4) were conducted in these 32 patients. ResultsAmong 32 HCV RNA-positive patients, the mean age was 42.1 years, with 22 males (68.8%). Genotype 3 was predominant (43.8%), followed by genotype 1 (25%). Cirrhosis was detected in 15.6% (5/32) by FibroScan. FIB-4 >3.25 showed 80% sensitivity and 95.5% specificity (AUROC 0.96) for detecting cirrhosis, outperforming APRI >1.5, which had 40% sensitivity and 90.9% specificity (AUROC 0.840). These results support the FIB-4 as a reliable, low-cost alternative to FibroScan for assessing fibrosis in low-resource settings. ConclusionFrom a large population screened over two years, only a small fraction demonstrated active HCV infection requiring treatment. Genotype 3 remains the most prevalent in Eastern India, associated with steatosis and progressive fibrosis. FIB-4 provides superior non-invasive prediction of cirrhosis compared to APRI, supporting its use in resource-limited settings.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predictors of In-hospital Mortality among Cirrhotic Patients in Ethiopia: A Multicenter Retrospective Study 96%
- Independent Assessment of a Point of Care HCV RNA Test by Laboratory Analytical Testing and a Prospective Field Study in the U.S 94%
- Seroprevalence and molecular characterization of viral hepatitis and HIV co-infection in the Central African Republic 94%
Similar papers in this journal
- Soluble angiotensin-converting enzyme 2 as a prognostic biomarker for disease progression in patients infected with SARS-CoV-2 91%
- Evaluation of VIDAS® diagnostic assay prototypes detecting dengue virus NS1 antigen and anti-dengue virus IgM and IgG antibodies 90%
- Thermoacoustic ultrasound assessment of liver steatosis - a novel approach for MASLD diagnosis 90%
Similar papers in this journal
- Rbpj deletion in hepatic progenitor cells attenuates endothelial responses and fibrosis in DDC-fed mice 91%
- Engagement with the HCV care cascade among high-risk groups: a population-based study 90%
- Hepatic MCPIP1 protein levels are reduced in NAFLD patients and are predominantly expressed in cholangiocytes and liver endothelium 90%
Similar papers in this journal
- Test-retest reliability of hepatic venous pressure gradient and impact on trial design: a study in 289 patients from the control groups of 20 randomized trials 89%
- Semaphorin 3C exacerbates liver fibrosis 88%
- Breakthrough SARS-CoV-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study 88%
Similar papers in this journal
- Impact of Losartan on Portal hypertension and Liver Cirrhosis: A Systematic Review 92%
- Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant 91%
- Post mortem pathological findings in COVID-19 cases: A Systematic Review 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.